IPP Bureau
Evonik showcases smart technology for dental prostheses
By IPP Bureau - July 05, 2023
PEEK brings a new quality to dental care for patients
Venus Remedies gets marketing approvals for oncology medicine from 4 key markets
By IPP Bureau - July 05, 2023
With this, the number of marketing approvals for its oncology products across 75 countries has gone up to 503
Merck India appoints Pratima Reddy as Country Speaker
By IPP Bureau - July 05, 2023
Pratima takes on the role of Country Speaker in addition to her role as GM and MD of Merck Specialties in India
Biocon Biologics expands footprint in emerging markets
By IPP Bureau - July 05, 2023
Takes over the commercialization of Biosimilars Business from Viatris in 70+ countries
Apex laboratories introduces OVAPEX Tablets for managing PCOS & female infertility
By IPP Bureau - July 05, 2023
OVAPEX is a unique formula developed by the team of scientists and doctors at Green Milk Concepts
Healthium Medtech appoints Dr. Vivek S. Iyer as GM for Professional Education & Market Growth Strategy
By IPP Bureau - July 05, 2023
Dr. Vivek joins Healthium after a stint at Ethicon, Johnson & Johnson
Solara Active Pharma approves rights issue of Rs. 450 Cr
By IPP Bureau - July 05, 2023
The detailed terms in relation to the Rights Issue, including but not limited to the issue price, rights entitlement ratio, record date, timing and terms of payment will be determined in due course.
BDR Pharma's Nilotinib sets a new standard in the treatment of Philadelphia Chromosome-positive leukaemia
By IPP Bureau - July 05, 2023
Rare childhood cancer subtype, Ph+ ALL, is found in 3-4% of pediatric cases and 25% of adult cases
Biocon Biologics' Hulio Biosimilar to Humira now available in the US
By IPP Bureau - July 04, 2023
The launch of HULIO in the United States is an important milestone for Biocon Biologics
Lupin receives approval from FDA for Cyanocobalamin Nasal Spray
By IPP Bureau - July 04, 2023
Cyanocobalamin Nasal Spray (RLD Nascobal) had estimated annual sales of USD 69 million in the U.S. (IQVIA MAT Mar 2023)
Adare Pharma divests Adare Biome to dsm-firmenich
By IPP Bureau - July 04, 2023
The transaction represents an enterprise value of €275 million, an estimated 2023 EV/EBITDA multiple of 18x
SHL Medical acquires 100% of the shares in LCA Automation
By IPP Bureau - July 04, 2023
SHL Medical announces the acquisition of LCA Automation AG, a Swiss innovative automation solutions provider
Anupam Rasayan signs MoU with 3xper Innoventure for new age pharma molecules
By IPP Bureau - July 04, 2023
The identified products for Active Pharmaceutical Ingredients (API) will be developed under the CRAMS and CDMO models
Alembic Pharmaceuticals receives USFDA approvals for 5 products in Q1FY24
By IPP Bureau - July 03, 2023
Alembic has a cumulative total of 184 ANDA approvals (159 final approvals and 25 tentative approvals) from USFDA.
Granules India successfully completes Two US FDA Audits in a span of 2 weeks
By IPP Bureau - July 03, 2023
The zero-observation outcome reflects the company's robust quality management systems and commitment to excellence in its operations.
